MARC details
| 000 -LEADER |
|---|
| fixed length control field |
00998nam a2200289 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
vtls000053397 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KUKTEM |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251117150501.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
110531t2011 sz a f 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783034600934 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
3034600933 |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
|---|
| Level of rules in bibliographic description |
201111031137 |
| Level of effort used to assign nonsubject heading access points |
asmadi |
| Level of effort used to assign subject headings |
201107140051 |
| Level of effort used to assign classification |
VLOAD |
| -- |
201105311600 |
| -- |
irma |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UMP |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
RC280.B8 D78 2011 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Drugs for HER2-positive breast cancer / |
| Statement of responsibility, etc. |
Maria Sibilia ... [et al.], editors |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Basel : |
| Name of publisher, distributor, etc. |
Springer, |
| Date of publication, distribution, etc. |
c2011 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
ix, 110 p. : |
| Other physical details |
ill. (some col.) : |
| Dimensions |
24 cm. |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Milestones in drug therapy |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Trastuzumab |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
BRCA genes |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Cancer |
| General subdivision |
Gene therapy |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Breast |
| General subdivision |
Cancer |
| -- |
Chemotherapy |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sibilia, Maria |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Milestones in drug therapy |